Nihon Chouzai Co (TSE:3341) Beneish M-Score: -2.57 (As of Jun. 26, 2026)


TSE:3341 Nihon Chouzai Co Ltd TSE:3341
51 GF Score
Price 円3,925.00
GF Value 円1,563.20
! 10 Warning Signs
View Full Analysis

What is Nihon Chouzai Co Beneish M-Score?

Nihon Chouzai Co TSE:3341 -0.13% 51 Beneish M-Score is -2.57 as of Jun. 26, 2026. GuruFocus rates TSE:3341 with a GF Score™ of 51/100 and a GF Value™ of 円1,563.20. The stock has 10 warning signs investors should review.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.57 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Nihon Chouzai Co's Beneish M-Score or its related term are showing as below:

TSE:3341' s Beneish M-Score Range Over the Past 10 Years
Min: -3.12   Med: -2.73   Max: -2.22
Current: -2.57

During the past 13 years, the highest Beneish M-Score of Nihon Chouzai Co was -2.22. The lowest was -3.12. And the median was -2.73.


Nihon Chouzai Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Nihon Chouzai Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nihon Chouzai Co Beneish M-Score Chart

Nihon Chouzai Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.76 -2.88 -2.45 -2.83 -2.57

Nihon Chouzai Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -2.57 0.00 0.00

Nihon Chouzai Co Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Nihon Chouzai Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nihon Chouzai Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nihon Chouzai Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Nihon Chouzai Co's Beneish M-Score falls into.


TSE:3341
51GF Score
Nihon Chouzai Co Ltd TSE:3341
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nihon Chouzai Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Nihon Chouzai Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0021+0.528 * 1.057+0.404 * 1.0155+0.892 * 1.0594+0.115 * 0.896
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.037711-0.327 * 0.9933
=-2.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was 円23,175 Mil.
Revenue was 円360,512 Mil.
Gross Profit was 円57,365 Mil.
Total Current Assets was 円96,962 Mil.
Total Assets was 円197,105 Mil.
Property, Plant and Equipment(Net PPE) was 円65,541 Mil.
Depreciation, Depletion and Amortization(DDA) was 円9,567 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円84,687 Mil.
Long-Term Debt & Capital Lease Obligation was 円43,956 Mil.
Net Income was 円1,391 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円8,824 Mil.
Total Receivables was 円21,830 Mil.
Revenue was 円340,310 Mil.
Gross Profit was 円57,236 Mil.
Total Current Assets was 円91,031 Mil.
Total Assets was 円195,087 Mil.
Property, Plant and Equipment(Net PPE) was 円70,331 Mil.
Depreciation, Depletion and Amortization(DDA) was 円9,061 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円84,858 Mil.
Long-Term Debt & Capital Lease Obligation was 円43,321 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23175 / 360512) / (21830 / 340310)
=0.064284 / 0.064147
=1.0021

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(57236 / 340310) / (57365 / 360512)
=0.168188 / 0.159121
=1.057

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (96962 + 65541) / 197105) / (1 - (91031 + 70331) / 195087)
=0.175551 / 0.172872
=1.0155

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=360512 / 340310
=1.0594

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(9061 / (9061 + 70331)) / (9567 / (9567 + 65541))
=0.11413 / 0.127377
=0.896

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 360512) / (0 / 340310)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((43956 + 84687) / 197105) / ((43321 + 84858) / 195087)
=0.652662 / 0.657035
=0.9933

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1391 - 0 - 8824) / 197105
=-0.037711

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Nihon Chouzai Co has a M-score of -2.57 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.57 mean?
Nihon Chouzai Co (TSE:3341) has a Beneish M-Score of -2.57 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nihon Chouzai Co and its competitors.
Is Nihon Chouzai Co's Beneish M-Score too high?
Nihon Chouzai Co's current Beneish M-Score is -2.57. Overall, Nihon Chouzai Co has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's Beneish M-Score compare to competitors?
Nihon Chouzai Co's Beneish M-Score of -2.57 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Nihon Chouzai Co and its competitors. Nihon Chouzai Co's current Beneish M-Score is -2.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (TSE:3341) has a current Beneish M-Score of -2.57. The stock's GF Value™ is 円1,563.20, compared to a current price of 円3,925.00 — trading 151.1% above its estimated fair value. The current Beneish M-Score is -2.57. Nihon Chouzai Co's overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Nihon Chouzai Co (TSE:3341), the current Beneish M-Score is -2.57 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nihon Chouzai Co (TSE:3341) Overvalued in 2026?

Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued. The current stock price of 円3,925.00 is trading 151.1% above its estimated GF Value™ of 円1,563.20.

Key valuation signals for TSE:3341:

  • Beneish M-Score: -2.57
  • GF Value™: 円1,563.20 vs. price of 円3,925.00 (151.1% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the TSE:3341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nihon Chouzai Co Business Description

Address Sapporo Odori Nishi Front Park 8 floors 7-1, Tokyo, JPN
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
51GF Score

Get the complete analysis for TSE:3341

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,925.00
Price
円1,563.20
GF Value